Effects of Exercise Behavior Modification on Plasma Adiponectin and Insulin Resistance in High Risk Subjects of Diabetes
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Investigators hypothesized home-based exercise intervention was beneficial to those who have had diabetic risk factor for type 2 diabetes mellitus
| Condition | Intervention |
|---|---|
|
Diabetes Mellitus |
Behavioral: Physical activity promoting intervention Behavioral: General instruction and education |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Outcomes Assessor) |
| Official Title: | Effects of Exercise Behavior Modification on Plasma Adiponectin and Insulin Resistance in High Risk Subjects of Diabetes |
- Plasma adiponectin level in μg/ml [ Time Frame: Nine months after the start of the intervention ] [ Designated as safety issue: No ]Fasting blood samples were centrifuged to obtain plasma and then immediately stored at -20℃. Plasma adiponectin levels were then determined through enzyme-linked immunoassay (ELISA).
- Exercise behavior [ Time Frame: Nine months after the start of the intervention ] [ Designated as safety issue: No ]
- Exercise self-efficacy: Measured by exercise self-efficacy questionnaire in score
- Physical activity: Meausred by 7-day recall questionnaire in kcal/kg/day
- Insulin resistance [ Time Frame: Three, 6 and 9 months after the start of the intervention ] [ Designated as safety issue: No ]plasma inulin level (μU/ml) meausred by AxSYM with HOMA-IR was caculated
- Metabolic components [ Time Frame: Three, 6 and 9 months after the start of the intervention ] [ Designated as safety issue: No ]
- Waist circumference (cm)
- Fasting blood samples were centrifuged to obtain plasma for plasma triglycerides (TG) and high-density lipoprotein (HDL) levels in mg/dl
- Plasma fasting glucose (FG) levels were measured in mg/dl by using the glucose oxidase membrane/hydrogen peroxide electrode method with the Antsense II analyzer (Bayer-Sankyo Co., Tokyo, Japan)
- Systolic blood pressure (SBP) and dystolic blood pressure (DBP) in mmHg
- Physical fitness [ Time Frame: Three, 6 and 9 months after the start of the intervention ] [ Designated as safety issue: No ]
- Body composition (kg/m^2): Body mass index that was weight in kilograms divided by the square of height in meter
- Flexibility (cm): Meausred by sit-and-reach test
- Grip strength (Nm): Measured by Jamar handheld dynameter
- Muscle endurance (times/min): Measured by sit-up test
- Cardiopulmonary fitness (3-minute step test)
- Dietary intake [ Time Frame: Three, 6 and 9 months after the start of the intervention ] [ Designated as safety issue: No ]Measured by 24-hour recall guestionnaire in kcal/kg/day
- Plasma adiponectin level in μg/ml [ Time Frame: Three and 6 months after the start of the intervention ] [ Designated as safety issue: No ]Fasting blood samples were centrifuged to obtain plasma and then immediately stored at -20℃. Plasma adiponectin levels were then determined through enzyme-linked immunoassay (ELISA)
- Exercise behavior [ Time Frame: Three and 6 months after the start of the intervention ] [ Designated as safety issue: No ]
- Exercise self-efficacy: Measured by exercise self-efficacy questionnaire in score
- Physical activity: Meausred by 7-day recall questionnaire in kcal/kg/day
| Enrollment: | 216 |
| Study Start Date: | January 2004 |
| Study Completion Date: | June 2005 |
| Primary Completion Date: | June 2005 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Lifestyle counseling
To promote participants' exercise behaviors with individualized home-based exercise program was designed based on the Health Belief Model and Transtheoretical Model
|
Behavioral: Physical activity promoting intervention
Other Names:
|
|
Control
Received oral instruction and written general education information without individualized exercise program
|
Behavioral: General instruction and education
Other Names:
|
Detailed Description:
This randomized clinical trial was designed to investigate whether a home-based exercise could improve adiponectin levels, exercise behavior and metabolic risk factors (insulin resistance, metabolic components and physical fitness) in subjects with at least a diabetic risk factor for type 2 diabetes mellitus. Participants were randomly allocated to either a control group or a home-based exercise group. All participants were evaluated for outcome measures at baseline, and at 3-month 6-month and 9-month follow-up after engaging in the intervention.
Eligibility| Ages Eligible for Study: | 20 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion criteria:
- At least one of the following criteria as following: BMI >=24 kg/m*m, hypertension, dyslipidemia, fist-degree relatives of parents with type 2 diabetes, impaired glucose tolerance, gestational diabetes and delivering a babt weighing >=4.0 kg
- Ability of understanding Chinese or Taiwanese
Exclusion Criteria:
- Diabetes
- Receiving treatment with insulin or oral hypoglycemic agents
- Any other serious illness that prohibit them to undertake fitness evaluation
Contacts and Locations| Taiwan | |
| National Taiwan University Hospital | |
| Taipei, Taiwan, 100 | |
| Study Director: | Ying-Tai Wu, Doctor | National Taiwan University Hospital |
More Information
Publications:
| Responsible Party: | Ying-Tai Wu/, National Taiwan University |
| ClinicalTrials.gov Identifier: | NCT01136096 History of Changes |
| Other Study ID Numbers: | 9261701067, DOH93-HP-1105, DOH94-HP-1105 |
| Study First Received: | May 23, 2010 |
| Last Updated: | June 2, 2010 |
| Health Authority: | Taiwan: Department of Health |
Keywords provided by National Taiwan University Hospital:
|
diabetes physical activity adiponectin |
metabolic risks exercise primary prevention |
Additional relevant MeSH terms:
|
Diabetes Mellitus Insulin Resistance Glucose Metabolism Disorders |
Metabolic Diseases Endocrine System Diseases Hyperinsulinism |
ClinicalTrials.gov processed this record on May 16, 2013